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ABSTRACT
Objective: Group B streptococcal (GBS) vulvovaginitis is a poorly-delineated clinical entity. The
purpose of this study is to report semiquantitative data from four cases ofGBS vulvovaginitis and
to comment on their significance in terms of the in vitro inhibitory capabilities of GBS.
Methodology: Four patients whose clinical presentations were consistent with GBS vulvovagini-
tis, from whom GBS was isolated and for whom semi-quantitative as well as qualitative microbio-
logic data existed, were identified.
Results: To produce vulvovaginitis, GBS must be at a high multiplicity (108 CFU/g of vaginal
fluid). Single coisolates were identified in three of the four cases (two cases of Escherichia coli and
one case of Staphylococcus aureus). Group B streptococcus does not inhibit either of these bacteria
in vitro.
Conclusion: When the growth requirements for the demonstration of in vitro inhibition for GBS
or lack thereof are met in vivo, the in vivo observations are consistent with those projected from the
in vitro data. Infect. Dis. Obstet. Gynecol. 7:227-229, 1999. (C) 1999 Wiley-Liss, Inc.
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ulvovaginitis due to the group B streptococcus
(GBS) is a poorly delineated clinical entity.
The medical literature and most books on sexually
transmitted diseases contain little or no information
dealing with GBS vulvovaginitis. Characteristically,
patients present with a chief symptom of vulvar
burning or pain. A significant vaginal discharge is
not a characteristic complaint. On physical exami-
nation, the labia minora will have a fiery-red to
cherry-red appearance, z The areas of erythema are
tender to touch.
Most clinical vaginal specimens are screened for
identifiable pathogens. Little regard is given to
bacteria concomitantly present. In reviewing re-
cords from a number of clinical vaginitis studies in
which more comprehensive microbiologic study
was performed, four women were identified who
had clinical symptoms, findings, and microbiologic
prerequisites that warranted the diagnosis of GBS
vulvovaginitis. The purpose of this paper is to char-
acterize their semiquantitative microbiologic data
as it relates to qualitative microbiologic observa-
tions dealing with GBS3 and to in vitro inhibition
data dealing with GBS.4
MATERIALS AND METHODS
Clinical Presentations
The primary symptom of all four patients was vul-
var burning or pain. Only one of the patients re-
ported significant vaginal discharge. The discharge
was described as creamy white. On physical exami-
nation, all four patients had fiery-red labia minora
that were edematous. In one patient, the erythema
Correspondence to: Gilles R.G. Monif, MD, Assistant Dean, Creighton University School of Medicine, 2500 California
Plaza, Omaha, NE 68178.
Received 8 January 1999
Clinical Study Accepted 21 June 1999GROUP B STREPTOCOCCAL VULVOVAGINITIS MONIF
TABLE I. Microbiologic data derived from patients
with GBS vulvovaginitis
Case number Bacterial isolates
GBS, >10 CFU/g E. coli >10 CFU/g
GBS > 10 CFU/g
GBS +4 growth, E. coli +4 growth
GBS, > 10 CFU/g S. aureus 10 CFU/g
extended to approximately 2 inches from the anus
and involved both labia. Vaginal examination re-
vealed marked mucosal tenderness. The vaginal
erythema was less intense than that which involved
the labia. No cervical motion tenderness was iden-
tified. The remainder of the physical examination
was unremarkable in all four patients.
Wet-mount examinations revealed an acid pH
with varying degrees of inflammatory exudate pre-
sent and the absence of lactobacillus on visual ex-
amination. When symptomatology was of long du-
ration, a significant number of reparative cells were
present. No protozoans or fungi were identified.
Microbiology
The quantitative microbiologic techniques used in
the clinical studies varied; the preweighted swab
technique was used in two cases, quantitative loops
were used in one case, and in the remaining case,
gross visualization of bacterial growth on a scale of
trace to +4 was used.s,6 The qualitative microbiol-
ogy was that which was standard for the research
studies. 7
RESULTS
The qualitative and semiquantitative microbiologic
data is listed in Table 1. In one case, GBS was the
sole isolate (case #2). In the remaining three cases,
a single coisolate was identified. In two cases, the
organism was Escherichia coli; in one case, the or-
ganism was Staphylococcus aureus.
DISCUSSION
In 1995, Chaisilwattana and Monif published a
comprehensive study on the in vitro ability of GBS
to inhibit gram-positive and gram-variable constitu-
ents of the bacterial flora of the genital tract.3 In
vitro, GBS was shown to inhibit other beta hemo-
lytic streptococci, diphtheroides, lactobacillus, and
Gardnerella vaginalis. Variable inhibition by GBS
was observed with viridans, streptococci, nonhemo-
lytic (not group B or D) streptococci, peptostrep-
tococci, and enterococci.3 The GBS strains tested
did not inhibit the growth of coagulase-negative
staphylococci, S. aureus, or any gram-negative or-
ganisms.
3 Isolates ofGBS were uniformly inhibited
by coagulase-negative staphylococci, but were not
inhibited by S. aureus.4 When quantitative studies
were performed analyzing the interrelationships
within the bacterial flora of the female genital tract,
GBS was found not to be an infrequent isolate with
either G. vaginalis, lactobacillus, or the coagulase-
negative staphylococci.4
These types of observations put the validity of
the in vitro inhibition data into question. The tech-
nique used to demonstrate in vitro inhibition re-
quired replication of GBS to the peak of its growth
curve (>108 CFU/g). What the quantitative data
presented in the study suggests is that when these
conditions or requisites of growth are achieved and
result in clinical disease, the in vitro observations
appear valid. In one of the four cases, GBS was the
sole isolate. In the three remaining cases, the single
coisolates were either E. coli or S. aureus, bacteria
not inhibited in vitro by GBS. None of the bacteria
inhibited by GBS were present. Of some interest
was the fact that, in contrast to E. coli, the multi-
plicity of S. aureus was low, suggesting there may
be some residual inhibitory influence over gram-
positive organisms that is lacking for gram-negative
bacteria, specifically, E. coll. When one reviews
cases of polymicrobial septicemia in large series, it
is not uncommon to find coisolation of group A or
B streptococci and E. coll. In a previously cited
study, Carlson et al. had suggested a possible facil-
itating interrelationship of S. aureus, GBS, and se-
lective Enterobacteriaceae.4
With limited observations, one must be very
cautious in the conclusions drawn from any such
studies; however, the unlikelihood that a large se-
ries subjected to rigorous qualitative semiquantita-
tive microbiology will be carried out in the near
future is reason to present the hypothesis that in
vitro and in vivo inhibition do correlate if one re-
produces the conditions required in terms of the
density of organisms per gram of vaginal fluid.
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